Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
4,234,235
Share change
-1,590,507
Total reported value
$10,372,895
Price per share
$2.45
Number of holders
35
Value change
-$6,125,369
Number of buys
17
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2018

As of 31 Mar 2018, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,234,235 shares. The largest 10 holders included FMR LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Sio Capital Management, LLC, JPMORGAN CHASE & CO, Opus Point Partners Management, LLC, Alethea Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.